Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02441335 · ClinicalTrials.gov registry record
CellulaR Injury and Preterm Birth
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 705
- Enrollment target
NCT02441335: Completed study, sponsored by University of Pennsylvania.
NCT02441335 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 705 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02441335 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 705 participants
- Enrollment target
Study Summary
The goal of this study is to examine how cellular dysfunction can lead to preterm birth. Women with singleton pregnancies with spontaneous preterm labor, preterm premature rupture of membranes, and cervical insufficiency (20 to 36-6/7 weeks gestation), and term deliveries (greater than 38 weeks) will be enrolled. Medical/obstetric history and pregnancy outcomes will be recorded. Maternal blood, urine and cervical cells (enrollment); cord blood and placental biopsy (delivery) will be collected.
Primary Outcome
The role of biogenetics in pregnancy and what are the perturbations in cell metabolism that lead to spontaneous preterm birth.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 705 participants |
| Start Date | 2015-01 |
| Est. Completion | 2019-08-01 |
What the finished NCT02441335 record still lists
NCT02441335 is an observational study that tracks outcomes without assigning an intervention. The registered 705 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02441335 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02441335 about?
NCT02441335 is a clinical study titled "CellulaR Injury and Preterm Birth". The goal of this study is to examine how cellular dysfunction can lead to preterm birth. Women with singleton pregnancies with spontaneous preterm labor, preterm premature rupture of membranes, and cervical insufficiency (20 to 36-6/7 weeks gestation), and term deliveries (greater than 38 weeks) wil...
What is the current status of trial NCT02441335?
This trial is currently completed. The enrollment target is 705 participants. The study started on 2015-01. Estimated completion is 2019-08-01.
Who is sponsoring clinical trial NCT02441335?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06480383 · 705 participants · Phase 2
Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder
- NCT07067463 · 705 participants · Phase 3
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
- NCT05796687 · 704 participants · NA
Evaluation of My Future Self, an New Teen Pregnancy Prevention Group Intervention for Youth in Non-traditional Settings
- NCT06350734 · 704 participants
Quality of Life After Treatment for Bladder Cancer: The Bladder Cancer Survivorship Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia